lactic acid has been researched along with tamoxifen in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (20.00) | 29.6817 |
| 2010's | 15 (60.00) | 24.3611 |
| 2020's | 4 (16.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Degani, H; Neeman, M | 1 |
| Kylmä, J; Nazhat, SN; Rich, J; Seppälä, J; Tanner, KE; Tuominen, J | 1 |
| Dhake, AS; Sehra, S | 1 |
| Hu, FX; Kang, ET; Neoh, KG | 1 |
| Arnold, DL; Assina, R; Caramanos, Z; Langleben, A; Leblanc, R; Preul, MC; Sankar, T; Villemure, JG | 1 |
| Basu, S; Mukherjee, B; Sahana, B; Santra, K | 1 |
| Godugu, C; Jain, AK; Jain, S; Singh, RP; Swarnakar, NK | 1 |
| Bilensoy, E; Calis, S; Capan, Y; Cirpanli, Y; Erdogar, N; Gegu, C; Launay, M; Leturgez, T; Ozturk, K; Yerlikaya, F | 1 |
| Mirzajani, F; Rafati, H | 1 |
| Bracht, A; Itinose, AM; Marek, CB; Peralta, RM | 1 |
| Flomenberg, N; Goldberg, A; Howell, A; Ko, YH; Lin, Z; Lisanti, MP; Martinez-Outschoorn, UE; Pavlides, S; Pestell, RG; Sotgia, F; Wang, C | 1 |
| Jain, AK; Jain, S; Thanki, K | 1 |
| Dey, NS; Maji, R; Mondal, S; Mukherjee, B; Satapathy, BS | 1 |
| Iqbal, Z; Khuroo, T; Padhi, S; Panda, AK; Talegaonkar, S; Verma, D | 1 |
| Ghosh, S; Haldar, C; Maiti, P; Pandey, SK | 1 |
| Haldar, C; Maiti, P; Maurya, AK; Mishra, DP; Pandey, SK; Patel, DK; Thakur, R; Vinayak, M | 1 |
| Chitkara, D; Kumar, P; Kumar, R; Raza, K; Singh, B; Thakur, CK; Thotakura, N | 1 |
| Paswan, SK; Saini, TR | 1 |
| Chen, Y; Cheng, X; Cui, Y; Guo, S; Guo, W; Ji, W; Jiang, H; Lan, Y; Li, J; Mao, L; Song, X; Wang, J; Wang, W; Wang, Y; Wu, N; Yang, H; Yang, X; Yu, Z; Zhou, B; Zhou, Q | 1 |
| Abu-Irmaileh, B; Al-Bawab, AQ; Al-Lakkis, L; Albustanji, S; Alhusban, AA; Hamadneh, L; Tarawneh, S | 1 |
| Albustanji, S; Alhusban, AA; Hamadneh, LA; Shallan, AI | 1 |
| Bellozi, PMQ; Itinose, AM; Koerich, S; Marek, CB; Sandrini, F; Schneider, SCS; Silva, FC | 1 |
| Di Stefano, G; Farabegoli, F; Govoni, M; Rossi, V | 1 |
1 trial(s) available for lactic acid and tamoxifen
| Article | Year |
|---|---|
Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Disease Progression; Female; Glioma; Humans; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons; Tamoxifen | 2008 |
24 other study(ies) available for lactic acid and tamoxifen
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Metabolic studies of estrogen- and tamoxifen-treated human breast cancer cells by nuclear magnetic resonance spectroscopy.
Topics: Breast Neoplasms; Cell Line; Estradiol; Glucose; Glutamates; Glutamic Acid; Humans; Lactates; Lactic Acid; Magnetic Resonance Spectroscopy; Phosphates; Phosphorylcholine; Tamoxifen | 1989 |
Lactic acid based PEU/HA and PEU/BCP composites: Dynamic mechanical characterization of hydrolysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Substitutes; Cisplatin; Composite Resins; Etoposide; Gamma Rays; Hydrolysis; Lactic Acid; Materials Testing; Mechanics; Mitoxantrone; Polyesters; Polyurethanes; Sodium Chloride; Sterilization; Tamoxifen | 2002 |
Formulation and evaluation of sustained release microspheres of poly-lactide-co-glycolide containing tamoxifen citrate.
Topics: Biocompatible Materials; Biodegradation, Environmental; Delayed-Action Preparations; Drug Compounding; Emulsifying Agents; Estrogen Antagonists; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polyvinyl Alcohol; Solubility; Solvents; Surface Properties; Tamoxifen | 2005 |
Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Shape; Drug Carriers; Estrogen Antagonists; Ferrosoferric Oxide; Humans; Lactic Acid; Nanoparticles; Particle Size; Polyesters; Polymers; Tamoxifen | 2006 |
Development of biodegradable polymer based tamoxifen citrate loaded nanoparticles and effect of some manufacturing process parameters on them: a physicochemical and in-vitro evaluation.
Topics: Breast Neoplasms; Chemical Phenomena; Drug Carriers; Drug Delivery Systems; Drug Stability; Estrogen Antagonists; Female; Humans; In Vitro Techniques; Lactic Acid; Microscopy, Electron, Scanning; Nanomedicine; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectroscopy, Fourier Transform Infrared; Tamoxifen | 2010 |
The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Female; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Tamoxifen | 2011 |
Comparative evaluation of in vitro parameters of tamoxifen citrate loaded poly(lactide-co-glycolide), poly(epsilon-caprolactone) and chitosan nanoparticles.
Topics: Biological Availability; Chitosan; Chromatography, High Pressure Liquid; Drug Compounding; Drug Delivery Systems; Electrochemistry; Estrogen Antagonists; Excipients; Lactic Acid; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Tamoxifen | 2010 |
Experimental design and desirability function approach for development of novel anticancer nanocarrier delivery systems.
Topics: Algorithms; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Drug Carriers; Drug Compounding; Drug Design; Excipients; Lactic Acid; Microscopy, Electron, Scanning; Models, Statistical; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Tamoxifen | 2011 |
Influence of tamoxifen on gluconeogenesis and glycolysis in the perfused rat liver.
Topics: Adenosine Triphosphate; Animals; Energy Metabolism; Fructose; Fructose-Bisphosphatase; Fumarate Hydratase; Gluconeogenesis; Glucose; Glucose-6-Phosphatase; Glycogen; Glycolysis; Lactate Dehydrogenases; Lactic Acid; Liver; Male; NAD; Nitric Oxide; Phosphoenolpyruvate Carboxykinase (ATP); Pyruvate Carboxylase; Rats; Rats, Wistar; Tamoxifen | 2011 |
Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Arsenic Trioxide; Arsenicals; Breast Neoplasms; Cell Line, Tumor; Coculture Techniques; Doxorubicin; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor Modulators; Female; Fibroblasts; Fulvestrant; Humans; Hypoglycemic Agents; Intracellular Signaling Peptides and Proteins; Ketone Bodies; Lactic Acid; Metformin; Mitochondria; Oxides; Phosphoric Monoester Hydrolases; Poly(ADP-ribose) Polymerase Inhibitors; Tamoxifen; Tumor Microenvironment | 2011 |
Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Caco-2 Cells; Female; Humans; Lactic Acid; Nanoparticles; Oxidative Stress; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Quercetin; Rats; Rats, Sprague-Dawley; Tamoxifen | 2013 |
Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Emulsions; Female; Humans; Lactic Acid; Microscopy, Electron; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spectroscopy, Fourier Transform Infrared; Surface Properties; Tamoxifen | 2014 |
Topotecan-tamoxifen duple PLGA polymeric nanoparticles: investigation of in vitro, in vivo and cellular uptake potential.
Topics: Animals; Antineoplastic Agents, Hormonal; Biological Transport; Drug Carriers; Female; Humans; Intestinal Absorption; Lactic Acid; MCF-7 Cells; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Wistar; Tamoxifen; Topoisomerase I Inhibitors; Topotecan | 2014 |
Therapeutic efficacy and toxicity of tamoxifen loaded PLA nanoparticles for breast cancer.
Topics: Animals; Breast Neoplasms; Drug Delivery Systems; Female; Humans; Lactic Acid; Nanoparticles; Rats; Rats, Wistar; Tamoxifen | 2015 |
Controlled release of drug and better bioavailability using poly(lactic acid-co-glycolic acid) nanoparticles.
Topics: Animals; Antineoplastic Agents; Apoptosis; Ascites; Biological Availability; Cell Death; Cell Line, Tumor; Cell Shape; Cell Survival; Delayed-Action Preparations; DNA Cleavage; Drug Liberation; Humans; Kinetics; Lactic Acid; Lymphoma; Mice; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Spectroscopy, Fourier Transform Infrared; Tamoxifen | 2016 |
Chitosan-modified PLGA polymeric nanocarriers with better delivery potential for tamoxifen.
Topics: Administration, Topical; Animals; Breast Neoplasms; Chitosan; Drug Carriers; Female; Humans; Lactic Acid; MCF-7 Cells; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Skin Absorption; Tamoxifen | 2016 |
Purification of Drug Loaded PLGA Nanoparticles Prepared by Emulsification Solvent Evaporation Using Stirred Cell Ultrafiltration Technique.
Topics: Antineoplastic Agents, Hormonal; Drug Carriers; Drug Contamination; Emulsifying Agents; Equipment Design; Lactic Acid; Membranes, Artificial; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Surface-Active Agents; Tamoxifen; Ultrafiltration | 2017 |
Brain Endothelial Cells Maintain Lactate Homeostasis and Control Adult Hippocampal Neurogenesis.
Topics: Animals; Blotting, Western; Brain; Cell Line; Cells, Cultured; Clustered Regularly Interspaced Short Palindromic Repeats; Cognition; Endothelial Cells; Female; Hippocampus; Lactic Acid; Male; Mice; Microscopy, Confocal; Monocarboxylic Acid Transporters; Neurogenesis; Real-Time Polymerase Chain Reaction; Tamoxifen | 2019 |
Changes in Lactate Production, Lactate Dehydrogenase Genes Expression and DNA Methylation in Response to Tamoxifen Resistance Development in MCF-7 Cell Line.
Topics: Breast Neoplasms; Cell Line, Tumor; DNA Methylation; Drug Resistance, Neoplasm; Female; Gene Expression; Gene Expression Regulation, Neoplastic; Glycolysis; Humans; L-Lactate Dehydrogenase; Lactic Acid; MCF-7 Cells; Prognosis; Promoter Regions, Genetic; Tamoxifen; Up-Regulation | 2021 |
Lactate and pyruvate levels correlation with lactate dehydrogenase gene expression and glucose consumption in Tamoxifen-resistant MCF-7 cells using capillary electrophoresis with contactless conductivity detection (CE-C
Topics: Breast Neoplasms; Electric Conductivity; Electrophoresis, Capillary; Female; Gene Expression; Glucose; Humans; L-Lactate Dehydrogenase; Lactic Acid; MCF-7 Cells; Pyruvic Acid; Tamoxifen | 2022 |
Alteration in glucose metabolism in the brain associated with tamoxifen treatment: Study in postmenopausal animal model.
Topics: Animals; Disease Models, Animal; Female; Glucose; Hippocampus; Humans; Hyperglycemia; Lactic Acid; Postmenopause; Pyruvic Acid; Quercetin; Rats; Tamoxifen | 2022 |
Lactate is a potential promoter of tamoxifen resistance in MCF7 cells.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug Resistance, Neoplasm; Female; Humans; Lactic Acid; MCF-7 Cells; Tamoxifen | 2022 |